Mitchell Ho

40PUBLICATIONS

130CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersComputational linguisticsAquaculture and fisheries stock assessment

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (40)

Sort by Publication Date:

|May 07, 2026

Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors.

|Apr 17, 2026

Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinoma.

|Jan 19, 2026

RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy.

Masanori Onda, Xiufen Liu, Wenlong Liu

|Jan 19, 2026

Recent advances in structural investigations of cancer antigen mesothelin and its interactions with therapeutic antibodies.

Jingyu Zhan, Mitchell Ho, Lothar Esser

|Jan 16, 2026

Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma.

Jinchutha Duangdara, Shaoli Lin, Jessica Hong

|Dec 15, 2025

Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics.

Philip Homan, Joon-Yong Chung, Woonghee Lee

Pageof 7

Frequent Collaborators

Ira Pastan

Bryan D Fleming

Jingyu Zhan

Nan Li

Stephen M Hewitt

Dan Li

Reona Okada

Rosa Nguyen

Hua Ren

Raffit Hassan

Frequent Collaborators

Ira Pastan

Bryan D Fleming

Jingyu Zhan

Nan Li